Time-resolved fluorescence resonance energy transfer assay for point-of-care testing of urinary albumin.

BACKGROUND Microalbuminuria is an established early marker of diabetic nephropathy and an important cardiovascular risk factor in diabetes and hypertension. We aimed to develop a rapid point-of-care assay for the measurement of urine albumin. METHODS The competitive homogeneous assay used an albumin-specific monoclonal antibody labeled with a stable fluorescent europium chelate as donor and an albumin labeled with cyanine 5 (Cy5) as acceptor. The assay was performed at room temperature in single microtitration wells that contained all the required dry-form reagents. The close proximity between the two labels in the immune complex allowed fluorescence resonance energy to be transferred from the pulse-excited europium chelate to the acceptor Cy5. The emission of long-lived energy transfer signal from the sensitized Cy5 was measured at 665 nm with time-resolved fluorometry that eliminated short-lived background. RESULTS The assay procedure required 12 min for a 10- micro L urine sample. The working range was from 10 to approximately 320 mg/L, and the lower limit of detection was 5.5 mg/L. The within- and between-run CVs were 6.9-10% and 7.5-13%, respectively. Recovery was 103-122%. The assay correlated well (r(2) = 0.98; n = 37) with a laboratory-based immunoassay, although mean (SD) results were 7 (29)% lower. CONCLUSIONS The speed and ease of performance of this assay recommend it for near-patient use. The assay is the first to combine a fluorescence resonance energy transfer-type rapid competitive assay with an all-in-one dry reagent.

[1]  P. Hurskainen,et al.  Terbium and rhodamine as labels in a homogeneous time-resolved fluorometric energy transfer assay of the beta subunit of human chorionic gonadotropin in serum. , 1999, Clinical chemistry.

[2]  T. Nordström,et al.  Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells. , 2001, Analytical biochemistry.

[3]  P Holownia,et al.  Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca analyzer. , 1997, Clinical chemistry.

[4]  J. Gross,et al.  The Receiver Operating Characteristics Curve in the Evaluation of a Random Urine Specimen as a Screening Test for Diabetic Nephropathy , 1997, Diabetes Care.

[5]  R. Seethala,et al.  A fluorescence polarization competition immunoassay for tyrosine kinases. , 1998, Analytical biochemistry.

[6]  K. Pettersson,et al.  One-step all-in-one dry reagent immunoassays with fluorescent europium chelate label and time-resolved fluorometry. , 1996, Clinical chemistry.

[7]  H. Mikola,et al.  Synthesis of europium(III) chelates suitable for labeling of bioactive molecules. , 1994, Bioconjugate chemistry.

[8]  Paul R Selvin,et al.  Principles and biophysical applications of lanthanide-based probes. , 2002, Annual review of biophysics and biomolecular structure.

[9]  K Irjala,et al.  Time-resolved fluorometry (TRF)-based immunoassay concept for rapid and quantitative determination of biochemical myocardial infarction markers from whole blood, serum and plasma. , 2000, Luminescence : the journal of biological and chemical luminescence.

[10]  T. Peters,et al.  Serum and urine albumin: a progress report on their measurement and clinical significance. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[11]  H. Parving,et al.  Prevention of diabetic renal disease with special reference to microalbuminuria , 1995, The Lancet.

[12]  L. Morrison,et al.  Time-resolved detection of energy transfer: theory and application to immunoassays. , 1988, Analytical biochemistry.

[13]  L. Mátyus,et al.  Application of fluorescence resonance energy transfer in the clinical laboratory: routine and research. , 1998, Cytometry.

[14]  C G Fraser,et al.  Desirable performance standards for clinical chemistry tests. , 1983, Advances in clinical chemistry.

[15]  J. Lakowicz,et al.  Homogeneous model immunoassay of thyroxine by phase-modulation fluorescence spectroscopy. , 1993, Analytical biochemistry.

[16]  Hervé Bazin,et al.  クリプテート発光の時間分解増幅 生物分子相互作用を追跡するための多才な技術 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2002 .

[17]  G. Lip,et al.  Microalbuminuria and cardiovascular risk. , 1998, QJM : monthly journal of the Association of Physicians.

[18]  Paul R. Selvin,et al.  The renaissance of fluorescence resonance energy transfer , 2000, Nature Structural Biology.

[19]  H. Bazin,et al.  Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions. , 2002, Journal of biotechnology.

[20]  G. Mathis,et al.  Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. , 1993, Clinical chemistry.

[21]  P. Huang,et al.  Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence. , 2000, Analytical biochemistry.

[22]  Maki Ukai-Tadenuma,et al.  A new technique to prevent self-ligation of DNA. , 2002, Journal of biotechnology.

[23]  Pertti Hurskainen,et al.  HOMOGENEOUS TIME-RESOLVED IL-2–IL-2Rα ASSAY USING FLUORESCENCE RESONANCE ENERGY TRANSFER , 1998 .

[24]  K. Dyke,et al.  Luminescence Immunoassay and Molecular Applications , 1990 .

[25]  J E Hearst,et al.  Luminescence energy transfer using a terbium chelate: improvements on fluorescence energy transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Woods,et al.  Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence. , 1999, Analytical biochemistry.

[27]  J. Bridges,et al.  Energy-transfer immunoassay: a study of the experimental parameters in an assay for human serum albumin. , 1980, Analytical biochemistry.

[28]  C. Fraser,et al.  Biologic variation of urinary albumin: consequences for analysis, specimen collection, interpretation of results, and screening programs. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  C. Price,et al.  Performance of a reagent strip device for quantitation of the urine albumin: creatinine ratio in a point of care setting. , 1999, Clinical nephrology.

[30]  G. Gauglitz,et al.  New donor-acceptor pair for fluorescent immunoassays by energy transfer. , 1999, Bioconjugate chemistry.

[31]  G. Watts,et al.  Microalbuminuria in Diabetes Mellitus: Review and Recommendations for the Measurement of Albumin in Urine , 1990, Annals of clinical biochemistry.

[32]  E. Soini,et al.  Time-Resolved Fluoroimmunoassay , 1988 .

[33]  U. Warrior,et al.  Homogeneous Time-Resolved Fluorescence Quenching Assay (LANCE) for Caspase-3 , 2002, Journal of biomolecular screening.

[34]  K. Pettersson,et al.  Ultrasensitive two-site immunometric assay of human lutropin by time-resolved fluorometry. , 1990, Clinical chemistry.

[35]  C. Price,et al.  Validation of a point-of-care assay for the urinary albumin:creatinine ratio. , 1999, Clinical chemistry.

[36]  M. Christiansen,et al.  Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome. , 2002, Clinical chemistry.

[37]  S. Josiah,et al.  Development of a Ubiquitin Transfer Assay for High Throughput Screening by Fluorescence Resonance Energy Transfer , 2000, Journal of biomolecular screening.

[38]  E. F. Ullman,et al.  Fluorescent excitation transfer immunoassay. A general method for determination of antigens. , 1976, The Journal of biological chemistry.

[39]  J. Lakowicz,et al.  Fluorescence energy transfer immunoassay based on a long-lifetime luminescent metal-ligand complex. , 1995, Analytical biochemistry.

[40]  C. Cullander.  Imaging in the far‐red with electronic light microscopy: Requirements and limitations , 1994, Journal of microscopy.